Search

everythinglearnresearchcommunity

for

Search:↓

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

Certain drugs can cause early hair growth in mice by affecting the nerves.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Gene therapy helped rats with a specific type of rickets grow hair without severe inflammation.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

PCPA induces hypersexual behavior in male rats regardless of age or castration status.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

PRP gel is a safe, affordable treatment needing trained staff and proper facilities.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

These medications for BPH have known risks and may have new side effects.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

LPR1 regulates root growth under low phosphate stress independently of SIZ1 in Arabidopsis thaliana.